BUSCOPAN Trademark

Trademark Overview

On Monday, April 2, 2012, a trademark application was filed for BUSCOPAN with the United States Patent and Trademark Office. The USPTO has given the BUSCOPAN trademark a serial number of 79113254. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Wednesday, April 3, 2019. This trademark is owned by Boehringer Ingelheim Pharma; GmbH & Co. KG. The BUSCOPAN trademark is filed in the Pharmaceutical Products category with the following description:

Antispasmodics, anticholinergics, analgesics, antacids, antiflatulents, antiulcerants
buscopan

General Information

Serial Number79113254
Word MarkBUSCOPAN
Filing DateMonday, April 2, 2012
Status711 - CANCELLED - SECTION 7
Status DateWednesday, April 3, 2019
Registration Number4239974
Registration DateTuesday, November 13, 2012
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, August 28, 2012

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesAntispasmodics, anticholinergics, analgesics, antacids, antiflatulents, antiulcerants

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateWednesday, April 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameA. NATTERMANN & Cie GMBH
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressDE
Party NameSanofi-Aventis Deutschland GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameBoehringer Ingelheim Pharma; GmbH & Co. KG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim Pharma; GmbH & Co. KG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Thursday, June 14, 2012SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Thursday, June 14, 2012LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, June 15, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 19, 2012APPLICATION FILING RECEIPT MAILED
Monday, July 16, 2012ASSIGNED TO EXAMINER
Friday, July 20, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 8, 2012NOTICE OF PUBLICATION
Wednesday, August 8, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 8, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, August 28, 2012PUBLISHED FOR OPPOSITION
Saturday, September 29, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 13, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, December 13, 2012GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Friday, December 14, 2012FINAL DISPOSITION PROCESSED
Friday, December 14, 2012FINAL DISPOSITION NOTICE SENT TO IB
Saturday, January 26, 2013NOTIFICATION PROCESSED BY IB
Thursday, March 7, 2013INTERNATIONAL REGISTRATION RENEWED
Friday, February 9, 2018CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, March 21, 2018CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Thursday, March 22, 2018NEW REPRESENTATIVE AT IB RECEIVED
Thursday, July 5, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 31, 2018REFUSAL PROCESSED BY IB
Friday, January 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 15, 2019TEAS SECTION 7 SURRENDER RECEIVED
Monday, March 4, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 15, 2019REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Wednesday, April 3, 2019CANCELLED SECTION 7-TOTAL
Friday, July 12, 2019NOTIFICATION PROCESSED BY IB
Tuesday, December 3, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 27, 2019INVALIDATION PROCESSED
Friday, December 27, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, January 9, 2020NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 24, 2020TOTAL INVALIDATION PROCESSED BY THE IB
Friday, February 7, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 7, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 14, 2023INTERNATIONAL REGISTRATION RENEWED
Friday, March 3, 2023CHANGE OF OWNER RECEIVED FROM IB
Thursday, May 14, 2026NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

buscopan antiflatulents antiulcerants antacids analgesics anticholinergics antispasmodics